The bipolar disorder is a kind of condition which affects all types of people. Children and adults are affected by this condition. This is a fact that you should know. Women would suffer the most from this kind of depression that is called bipolar depression disorder.
This is not really strange or far-fetched in any case because even if the women would suffer from the regular bipolar type of depression or depressive disorder, they are going to spend more time depressed than they would do being manic. Not only women are depressive but the men also are and they could also be affected by this condition.
The bipolar kind of disorder is also known as manic depression since such is a mental condition wherein you interchange often between such phases of depression and mania. When you suffer from bipolar depression, you will not have to spend as much time being manic as you spend being depressed.
This kind of depression is one form of disorder and you should understand it is easy to wrongly diagnose as bipolar disorder due to the similarity of such symptoms. Due to such, the doctor should keep you around for a long time when they are going to try to diagnose the condition which you have. It certainly won’t be flattering to either of you when you are treated for a wrong thing.
The bipolar affective disorder is another name for such bipolar disorder or the manic-depressive illness. But, you don’t like to mistake this for bipolar depression disorder. This is closely related with the symptoms of the depressive phase of the bipolar disorder but just a few of the mania.
Monotherapy trials against the placebo is the gold-standard design when determining the efficacy in treating bipolar depression. If the efficacy would get proven as monotherapy, those new compounds can be tested in the adjunctive-medication placebo-controlled trials. The younger adults, without the need for the long-term medication can be fit for the clinical trials which need placebo-controls. The switch to mania or hypomania can be the consequence of such active treatment for the bipolar depression.
Some of the medications like the tricyclic antidepressants as well as venlafaxine can be more likely to prove switch than the others but the increased rate of the switch cannot be seen until around ten weeks of treatment. Hence, the 12-week trials against placebo are required to determine such risk of switch and to establish such continuing effects. You should know that careful assessment at 6-8 weeks are required to make sure that the patients who fail to respond won’t continue in the study for the unacceptable periods of time.